Check out our Integrated Perinatal and Postnatal Strategies for Infants with Prenatal Substance Exposure collection here.
Maternal Health, Neonatology and Perinatology is a fully open access journal that publishes research spanning maternal health, fetal and neonatal medicine, and infant outcomes, with a focus on improving care throughout the continuum from pregnancy to early life. The journal welcomes clinical, epidemiological, and translational research that advances understanding of conditions affecting mothers and infants and supports evidence-based practice in perinatal care.
As rates of opioid and polysubstance use during pregnancy continue to pose significant challenges for healthcare systems worldwide, there is growing recognition of the need for coordinated, compassionate care that supports both mothers and infants. The collection Integrated Perinatal and Postnatal Strategies for Infants with Prenatal Substance Exposure brings together expertise and evidence on innovative models of care spanning pregnancy, the neonatal period, and early childhood. We spoke with Guest Editor Dr Anirudha Das about why this topic is so timely and where future research is needed.
From your perspective as Deputy Editor of Maternal Health, Neonatology and Perinatology, what makes this collection particularly timely?
The care of infants with prenatal substance exposure has evolved dramatically over the past decade. We have moved beyond focusing solely on treating withdrawal symptoms to recognizing prenatal substance exposure as a complex maternal–infant health issue that requires coordinated care across pregnancy, the neonatal period, and early childhood. At the same time, practices such as Eat, Sleep, Console (ESC), rooming-in, trauma-informed care, and integrated addiction services are being adopted worldwide, yet significant variation remains in implementation and outcomes. This collection provides an opportunity to evaluate emerging evidence, identify best practices, and help define a more standardized, family-centered approach to care.
The collection notes the increasing prevalence of opioid and polysubstance use during pregnancy. What are some of the most pressing challenges facing affected mothers and infants today?
One of the greatest challenges is that these families often face multiple overlapping vulnerabilities. Mothers frequently experience mental health disorders, housing insecurity, poverty, limited access to prenatal care, and fear of stigma or legal consequences, all of which can delay engagement with healthcare services. Infants have feeding difficulties, prolonged hospitalization, disrupted maternal–infant bonding, inconsistent follow-up, and uncertainty regarding long-term neurodevelopmental outcomes, all of which are challenges that require close attention.
What are the biggest evidence gaps that researchers still need to address in this area?
Although short-term management of neonatal withdrawal has improved, many important questions remain unanswered. We need robust prospective studies evaluating the long-term neurodevelopmental, behavioral, and growth outcomes of infants with prenatal substance exposure while carefully accounting for confounding factors such as socioeconomic disadvantage, caregiver stability, trauma, and polysubstance exposure. Additional evidence is also needed to determine which integrated care models—including ESC, rooming-in, breastfeeding support, telehealth, and structured developmental follow-up—produce sustained improvements beyond the hospitalization.
How can healthcare systems better support both mothers and infants while reducing stigma around substance use disorders?
Healthcare systems should recognize substance use disorder as a chronic medical condition rather than an issue of morality. Care should be trauma-informed, nonjudgmental, and centered on the mother–infant dyad. Integrating obstetric care, addiction medicine, neonatology, mental health services, lactation support, social work, and developmental follow-up can improve continuity of care while reducing barriers to treatment.
In one sentence, why should readers care about this issue?
Every infant affected by prenatal substance exposure deserves the opportunity to reach their full potential, and achieving that goal requires evidence-based, compassionate care that supports both the child and the family from pregnancy through early childhood.